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Abstract Microorganisms are a promising source of an
enormous number of natural products, which have made
significant contribution to almost each sphere of human,
plant and veterinary life. Natural compounds obtained from
microorganisms have proved their value in nutrition,
agriculture and healthcare. Primary metabolites, such as
amino acids, enzymes, vitamins, organic acids and alcohol
are used as nutritional supplements as well as in the pro-
duction of industrial commodities through biotransforma-
tion. Whereas, secondary metabolites are organic
compounds that are largely obtained by extraction from
plants or tissues. They are primarily used in the biophar-
maceutical industry due to their capability to reduce
infectious diseases in human beings and animals and thus
increase the life expectancy. Additionally, microorganisms
and their products inevitably play a significant role in
sustainable agriculture development.
Keywords Microorganisms  Metabolites  Healthcare 
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Introduction
Microorganisms are of immense importance to environ-
ment and essential to all life forms, and are primary source
of nutrients and act as chief recycler in environment (Bisen
et al. 2012). Microorganisms are present in extremely large
sphere of environment and thrive from abyssal zone to
stratosphere (at heights up to 60 km) and in a wide range of
temperatures ranging from arctic ice to boiling volcanoes
(Imshenetsky et al. 1978; Wainwright et al. 2006). These
microscopic organisms are used in the preparation of
variety of foods and also used as a source of food and feed
supplements. For example, amino acids are obtained from
Corynebacterium, Brevibacterium and Escherichia coli;
vitamins from Propionibacterium and Pseudomonas;
organic acids from Aspergillus, Lactobacillus, Rhizopus,
and enzymes from Aspergillus, Bacillus (Shimizu 2001;
Gurung et al. 2013; Mahmood 2015; Sun et al. 2015).
Microbes have been recognized considerably for their
potential in the development of bioprocess technologies for
unhindered production of food products and supplements to
meet increasing demand by continuously growing world
population. In addition, microorganism-based methodolo-
gies do not constitute a major source of pollution, and
therefore, are preferred alternative for overcoming serious
environmental problems, which arise from the conven-
tional chemical methods.
According to Business Communication Company
(BCC), the total global market for microbes and microbial
products was estimated at nearly $143.5 billion in 2014,
and is expected to reach nearly $306 billion at a compound
annual growth rate (CAGR) of approximately 14.6% over
the period from 2015 to 2020 (Microbial Products 2015).
New technologies for the production of microbial products
are replacing synthetic production processes due to
& Anshumali Mittal
anshumalijnu@gmail.com
& Praveen Kumar Mehta
mehtapkbiotech@gmail.com
1 Department of Biochemistry, VP Chest Institute, University
of Delhi, Delhi 110007, India
2 Mill Hill Laboratory, Division of Structural Biology and
Biophysics, The Francis Crick Institute, London, UK
3 Centre for Molecular Biology, Central University of Jammu,
Raya-Suchani, Bagla, Dist. Samba, J&K 181143, India
123
3 Biotech  (2017) 7:15 
DOI 10.1007/s13205-016-0586-4
technical and economical advantages. These products
include nutrition supplements such as, vitamins and amino
acids, organic acids, agriculturally important metabolites,
enzymes, flavoring agents, coloring agents and pharma-
ceutical products (Demain 2007). Healthcare was the lar-
gest end-user market for microbes and microbial products
at about $100.4 billion in 2014, and expected to increase to
nearly $111.5 billion by 2015, and over $187.8 billion by
2020. The large size of the healthcare market reflects the
importance of microbe-based biopharmaceutical industry
(Microbial Products 2015).
Primary metabolites include amino acids, nucleotides,
and fermentation end products such as ethanol and organic
acids, which are considered essential for proper growth of
microorganisms. Microbial synthesis is becoming the
dominant and optimal process for amino acid production
because of its ease to produce enantiomerically pure amino
acids at low cost and ecological acceptability (Sun et al.
2015). Secondary metabolites are organic compounds that
form at the end or near the stationary phase of growth, and
are not directly associated with growth, development, and
reproduction of microorganisms. These products are lar-
gely involved in healthcare activities as antimicrobial
agents, antiparasitic agents, antitumor, enzyme inhibitors
and immunosuppressive etc. (Demain 1999).
The serendipitous discovery of antibiotic penicillin by
Fleming in 1929 has drawn the interest of scientists to
investigate the therapeutic role of microbial products for
combating life-threatening infections. This lead to mass
production of antibiotics during World War II by surface
culture techniques and the period till 1960 was called as
golden age of antibiotics. For the discovery and concept of
antibiotics in infectious disease therapy Alexander Flem-
ing, Howard Florey and Emst Boris Chain shared Nobel
Prize in physiology/medicine in 1945. Since then, a large
number of soil as well as marine microorganisms have
been explored for their inexhaustible involvement in
pharmaceutical industry. The products derived from
microbes are inevitably used to control and cure many
infectious diseases acting as antibacterials, cholesterol
lowering agents, immunosuppressants, anthelmintics and
antiparasitic drugs (Demain and Sa´nchez 2009).
Secondary metabolites with activities as plant growth
stimulants, herbicides and insecticides have also been
reported. Some metabolites, such as adriamycin, bleomy-
cin, daunomycin, and mithramycin were used as antitumor
compounds (Kieslich 1986). In addition, secondary
metabolites are also used as anesthetics, anti-inflammatory
agents, anti-coagulants, anabolics, hemolytics, hypoc-
holesterolemics and vasodilatories (Bentley 1997). Differ-
ent strategies have been considered for effective and
overproduction of primary metabolites, where genetic and
physiological manipulations have played a significant role.
These methods include over-expression of genes involved
in metabolite synthesis, knockout of genes involved in
degradation, over expression of associated coenzymes and
continuous extraction of metabolites from the culture
(Tamano 2014).
In this communication, we are precisely illustrating the
roles of microbial metabolites in nutrition, healthcare and
agriculture with their current industrial status. The role of
microorganisms as a potential source of food and feed
supplements, and antimicrobial and antitumor properties in
healthcare are emphasized.
Amino acids
The amino acids are building blocks of protein molecules
and hence used in dietary and feed supplements of human
and animals, respectively (Mahmood 2015). These organic
molecules have various role, such as animal feed additives
(lysine, methionine, threonine), flavor enhancers (aspartic
acid, monosodium glutamate, serine), antioxidants (cys-
teine, L-tryptophan and L-histidine), as sweeteners (aspar-
tame made from aspartic acid and phenylalanine), and
ingredients in cosmetic and medicinal products (Bommar-
ius et al. 1998; Ikeda 2003; Mueller and Huebner 2003;
Leuchtenberger et al. 2005; Park and Lee 2008; Ivanov
et al. 2014). Additionally, amino acids are suggested as
dietary supplements for body building, bruxism, depres-
sion, sleep aid, premenstrual dysphoric disorder, attention
deficit-hyperactivity disorder, and smoking cessation. Non-
essential amino acids can be synthesized by human body
but essential amino acids cannot be synthesized in human
body but are required for protein synthesis and therefore,
dietary supplement is necessary from external sources.
Hence, production of essential amino acids at industrial
scale using microbial sources is promising and desirable.
The worldwide production technology for amino acids is
dominated by microbial fermentation and enzymatic pro-
cesses owing to cost-effectiveness, ecological acceptability
and ease to produce enantiomerically pure amino acids
(Ikeda 2003; Becker and Wittmann 2012).
The worldwide production of amino acids was about 6.5
million tons in 2014 and is expected to reach 10 million tons
of value nearly $35 billion by 2022 (Amino Acids Market
2015). The commercial production through fermentations
and enzymatic transformations mainly use Corynebac-
terium glutamicum and Escherichia coli to produce L-glu-
tamic acid (monosodium glutamate), L-aspartic acid, L-
phenylalanine, L-lysine, L-methionine, L-threonine, and L-
tryptophan. L-lysine is a preferred additive to animal feed
and approximately, 1.3 million tons of lysine is produced
annually through microbial fermentation using C. glutam-
icum (van Ooyen et al. 2012; Sun et al. 2015).
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L-Glutamate, extensively used in food and beverage
industry as flavor enhancer, was accounted for almost 40%
of whole amino acids volume in 2014. The global L-glu-
tamate market was valued over $8.0 billion in 2014 due to
increased application in food and beverages industries as
flavor enhancer and in pH regulation (Amino Acids Market
2015). L-Glutamate is a vital element of aged or fermented
foods, such as cheese and soy sauce. Microorganisms of the
genus Brevibacterium, Corynebacterium, Micrococcus and
Microbacterium are used for the fermentative production
of glutamate (Sanchez and Demain 2008; Mahmood 2015).
The chief amino acids used as animal feed additives are
lysine, methionine, threonine and tryptophan. The
increasing demand of these amino acids are coupled with
rising meat consumption as these feed ingredients are
essential for good health and regulate metabolic processes
of the livestock, such as swine, broiler and cattle to gain
faster growth and appropriate weight (Amino Acids Market
2015).
Animal feed was reported as the largest consumer of L-
lysine and accounted for approximately 92% of total
market volume in 2013. The world market of L-lysine is
expected to reach 2.8 million tons of value nearly $7 billion
by 2020, at a CAGR of 6.0% from 2014 to 2020 (Lysine
market analysis 2014). L-glutamate and L-lysine, main food
flavoring and feed ingredients, were produced over 5 mil-
lion tons in 2013 and the industrial market for amino acids
is increasing at a yearly growth rate of 6-8% (Becker and
Wittmann 2012; Wendisch 2014; Sun et al. 2015). Aro-
matic amino acids, such as L-tyrosine, L-phenylalanine and
L-tryptophan, are vital amino acids for human diet and
important precursors for the production of high value by-
products (nitric oxide, polyamines, glutathione, taurine,
thyroid hormones, serotonin etc.) (Polen et al. 2005; Sun
et al. 2015). The leading manufacturers worldwide are
Cargill, Novus, Ajinomoto, ADM, Evonik, DSM and Pri-
nova (Amino Acids Market 2015). The microbial tech-
nology has made a significant progress for large-scale
amino acids production to meet unhindered supply for
increasing demands, using constantly improving biotech-
nology manufacturing methods involving genetic and
metabolic engineering and physiologically manipulations
(Barker and Campbell 1981; Wang et al. 2001; Hartmann
et al. 2003; Znad et al. 2004; Demain 2007).
Vitamins
Vitamins are essential micronutrients required in trace
amount to maintain normal physiological function of the
body. These vital nutrients are not synthesized by mam-
mals, and therefore, dietary supplement is necessary from
external sources to maintain the balanced metabolism in all
living organisms (Shimizu 2001; Gupta and Gupta 2015).
Some vitamins are required as coenzymes to facilitate the
biochemical reactions catalyzed by the enzymes. Vitamin
K is required for normal blood clotting and also to activate
receptor to facilitate transcription mechanisms in bone
tissues, and to treat osteoporosis (Berg et al. 2002;
Bolander 2006). Vitamin A is required as precursor to
rhodopsin and other visual pigments, and also associated
with specific gene transcription activation that facilitates
growth and development (Berg et al. 2002). Vitamins are
produced during regular metabolism of microorganisms
and widely used as food additives, health supplements, and
therapeutic agent etc. Vitamins are produced commercially
either through direct fermentation or combined chemical
and microbiological processes using appropriate microor-
ganisms (Shimizu 2001; Bhalla et al. 2007). According to a
Global Strategic Business Report, the global market of
vitamins is expected to reach over $9.0 billion by 2020 due
to increasing health awareness and adoption of precau-
tionary healthcare practices (Vitamins 2015).
Riboflavin (vitamin B2), a water soluble vitamin, is
essential for growth and reproduction in humans and ani-
mals. Vitamin B2 deficiency results in cheilosis and der-
matitis in humans. The annual production was estimated
4.6 million kg and the leading producer of riboflavin are
Hoffmann-La Roche (Switzerland), BASF (Germany),
ADM (USA), Takeda (Japan) (Demain 2007). The chief
microorganisms used in the fermentative production of
riboflavin are two closely related ascomycetes, Eremothe-
cium ashbyii and Ashbya gossypii. A. gossypii is an effi-
cient and preferred source of riboflavin production as it can
produce 40,000 times more vitamin than required for its
own growth. Genetically engineered Bacillus subtilis and
Corynebacterium ammoniagenes are other bacterial species
preferred for riboflavin biosynthesis (Survase et al. 2006).
Cyanocobalamin (vitamins B12), an anti-pernicious
anemia factor, is required in trace amounts (almost
1 lg/day) and produced commercially exclusively by fer-
mentation process using Propionibacterium shermanii and
Pseudomonas denitrificans. These microbes manufacture
100,000 times more vitamin than they require for their own
growth (Kusel et al. 1984; Spalla et al. 1989; Demain
2007).
b-Carotene, pro-vitamin A, is required for vision, proper
growth and reproduction. The deficiency or malabsorption
of vitamin A causes night blindness, changes in the skin
and mucosal membranes (http://www.fao.org/docrep/004/
y2809e/y2809e0d.htm). The microorganisms Blakeslea
trispora, Phycomyces blakesleeanus, Mucor circinelloides,
Rhodotorula spp. and Choanephora cucurbitarum are used
for the production of b-carotene. Among these microbial
strains, Blakeslea trispora and Phycomyces blakesleeanus
are preferred and used for the industrial production by
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submerged fermentation due to high yield of b-carotene
(Wang et al. 2012; Mata-Gomez et al. 2014).
Enzymes
Catalytic activities of microbes have been utilized since
ancient times for production of bread, wine, and beer.
Enzymes derived from microorganisms have drawn sig-
nificant attention for extensive applications in food,
chemical and healthcare industries due to ease of produc-
tion, stability, and other technical advantages and there-
fore, microorganisms are utilized in industries as the
preferred source of enzymes than other sources of enzymes
production, such as animals and plants The use of biocat-
alytic activities in several industries including food, feed,
leather, textiles are increasing rapidly due to time saving
process, cost effectiveness, biodegradable nature and
environmental friendly characteristics (Gurung et al. 2013;
Adrio and Demain 2014; Singh et al. 2016). Besides,
microbial enzymes are also involved in the potential
degradation of toxic chemical compounds, such as phenolic
compounds, nitriles, amines etc. of industrial and domestic
wastes (Li et al. 2012; Choi et al. 2015). The biotechno-
logical developments have led to the manipulation of the
microorganisms through recombinant DNA technology,
protein engineering and their production in appropriate
quantities to meet the demand (Liu et al. 2013). According
to a market analysis, the global market of industrial
enzymes was estimated $4.2 billion in 2014 and is pre-
dicted to grow at compound annual growth rate (CAGR) of
7% from 2015 to 2020 (Industrial Enzymes Market 2015).
In healthcare industries, enzymes are used in therapeutic
management of health disorders caused due to enzyme
deficiencies in humans (Vellard 2003; Anbu et al. 2015).
For example, phenylalanine ammonia lyase is used in
degradation of phenylalanine in persons with inherited
phenylketonuria disorder (Sarkissian et al. 1999). Besides,
sacrosidase (b-fructofuranoside fructohydrolase) enzyme is
given to facilitate digestion of sucrose in patients with
genetic congenital sucrase-isomaltase deficiency as they
are incapable of digesting sucrose (Treem et al. 1999).
Utilization of microbial enzymes for different purposes in
food, pharmaceutical, textile, paper, leather, and other
industries are extensive and incessantly increasing over
conventional methods owing to higher effectiveness.
Table 1 illustrated applications of few enzymes and their
function in respective industries (Kamini et al. 1999;
Gurung et al. 2013; Adrio and Demain 2014).
The prospects of enzymes of microbial origin for
industrial applications have grown significantly in the 21st
century and their valuable contribution in food industry
may be used to meet incessantly growing demand of food
supply for rapidly growing population. Furthermore, these
are used in development of alternative fuel supply to
overcome the issues associated with depletion of natural
resources and in the development of green environment.
Organic acids
Organic acids are among the most versatile ingredients in
food, beverages, pharmaceuticals, solvents, petrochemi-
cals, textile, detergents, detergents, pharmaceuticals, rub-
ber, perfumes, plastics, dyes and adhesives (Sun et al.
2015). In addition, they are used widely in the production
of chemicals that are utilized in the automotive and con-
struction industries. The catalytic potential of microbes is
used in commercial production of several organic acids,
such as acetic acid, lactic acid, gluconic acid, citric acid
(Sauer et al. 2008). Global market of organic acids was
estimated at approximately $12 billion in 2014 and is
expected to reach over $18 billion by 2023. Increasing
demand of vinyl acetate monomer in food packaging
industry and high growth of pharmaceutical industry are
among major driving factors for huge growth in market
(Carboxylic Acid Market 2015).
Citric acid is used for a wide range of applications in
food industries, such as acidulant, flavorant, preservatives,
sequestrant, emulsifiers, and buffering agent. The global
market of citric acid was $2.6 billion in 2014 and is
expected to reach $3.6 billion by 2020 at a CAGR of 5.5%
from 2015 to 2020 (Citric Acid Market 2015). Incessant
growth in the production of citric acid is linked with
increasing demands in food, beverages, cosmetic industries
and personal care products. About 99% production of total
citric acid occurs via microbial processes using surface or
submerged cultures and approximately, 70% citric acid of
total production is used as an acidifier or antioxidant in
food and beverage industry to preserve or enhance the
flavors and aromas of fruit juices, ice cream, and mar-
malades (Lancini 2008). Aspergillus sp. and several other
yeasts Candida catenula, C. guilliermondii, C. tropicalis
and Yarrowia lipolytica are employed for the production of
citric acid (Kubicek 2001). Among microorganisms, two
closely related species of the genus Aspergillus, A.
niger and A. wentii are used for industrial production using
metabolic engineering (Max et al. 2010).
Itaconic acid is an important building block in the
chemical industry for the production of resins, plastics,
paints, and synthetic fibers. It is one of the top 12 building
block chemicals and a good substitute for acrylic or
methacrylic acid, which are used for the production of
plastics (Kawamura et al. 1981; Steiger et al. 2013; Otten
et al. 2015). The global market of itaconic acid market was
estimated $126.4 million in 2014 and is expected to grow
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at a CAGR of 5.5% between 2015 and 2023. The high
demand for itaconic acid is in the manufacturing of
superabsorbent polymers (SAP), which are used in diapers,
adult incontinence and feminine hygiene products (Itaconic
Acid Market 2015). It also finds large application in food
packaging, paints and coatings, emulsifiers, pharmaceuti-
cals, detergents, agriculture, herbicides and printing
chemicals (Itaconic Acid Market 2015). Several microor-
ganisms such as Ustilago, Candida, and Rhodotorula are
capable of producing itaconic acid, but only Aspergillus
terreus is preferred in commercial production of itaconic
acid due to high yield up to 80 g/L (Tabuchi et al. 1981;
Willke and Vorlop 2001; Okabe et al. 2009; Steiger et al.
2013).
Lactic acid is utilized extensively in food and beverages,
polymer, pharmaceutical, personal care products, and other
industries. The poly lactic acid polymer is biodegradable
and biocompatible, and used in pharmaceutical industry for
the synthesis of prosthetic devices, sutures and internal
drug dosing (San-Martin et al. 1992; Chahal and Starr
2006). The poly lactic acid has several applications in
packaging, agriculture, automobile, healthcare, electronics,
textile, and other industries (Ghaffar et al. 2014; Singhvi
et al. 2010; Martinez et al. 2013). The global lactic acid
market is expected to reach $3.8 billion by 2020 at a
CAGR of 18.6% from 2015 to 2020, whereas the global
polylactic acid market is estimated to reach nearly $5.16
billion by 2020, growing at a CAGR of 20.9% for the same
period (Lactic Acid Market 2015). L (?) lactic acid is
produced commercially through fermentation using lactic
acid bacteria (Lactobacillus sp.) or fungi (Rhizopus oryzae)
in submerged culture. Lactic acid producing bacteria are
preferred over fungi as the yield of lactic acid is very high
through bacterial mediated fermentations. Stereochemi-
cally pure L-(?)-lactic acid is solely produced by Rhizopus
oryzae (Martinez et al. 2013). The global chief
Table 1 Few microbial enzymes with their source and uses
Enzymes Source Industry Function









Faster cheese ripening, flavor
Dough stability and conditioning
Pitch control






Protease Aspergillus niger, A. flavus, B. subtilis, Pseudomonas sp.,
















Cotton softening, denim finishing
Colour clarification
Deinking, drainage improvement
Amylase Aspergillus sp., Bacillus subtilis, B. licheniformi,










Flour adjustment, bread softness
Deinking, drainage improvement
Desizing









Non-chlorine Bleaching, fabric dyeing
Hair dye
Polymerization of bisphenol A
Non-chlorine bleaching, delignification
Detoxification
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manufacturers of lactic acid are BASF SE (Germany),
CSM N.V. (The Netherlands), The Dow Chemical Com-
pany (U.S.), Teijin Ltd. (Japan), and Nature Works LLC
(U.S) (Lactic Acid Market 2015).
The global market for acetic acid is estimated approxi-
mately $9.0 billion and expected to reach nearly $12 billion by
2022 at a CAGR of 6.8% from 2015 to 2022 (Acetic Acid
Market 2016). Acetic acid is used in the synthesis of other
chemical commodities, such as acetic anhydride, vinyl acetate
monomer, acetate esters and purified terephthalic acid. These
chemicals are further used in wide range of industries such as
textiles, construction, automobile, pesticides and food ingre-
dients amongothers.Vinyl acetatemonomer, used in adhesive
and sealant industry, was accounted for highest (*33%)
consumption of the global acetic acid followed by ester sol-
vents in 2014. A variety of bacteria such as Acetobacter,
Gluconacetobacter, and Gluconobacter are used for com-
mercial production (Deppenmeier et al. 2002; Demain 2007).
In 2014, the acetic acid production amounted to 12 million
tons and is expected to reach a volume of nearly 17 million
tons by 2022 at a CAGR of 4.7% during the forecast period
(Acetic acid market 2016).
Besides, microorganisms are also used commercially for
the fermentative production of gluconic acid by Aspergillus
niger and Aureobasidium pullulans, succinic acid by Ac-
ctinobacillus succinogenes and pyruvic acid by Torulopsis
glabrata (Zeikus et al.1999; Li et al. 2001; Znad et al.
2004; Anastassiadis et al. 2005; Demain 2007). Major
manufacturers in organic acids market are Bioamber,
Genometica, GSM cargil and Dow Chemicals.
Alchohol
Ethanol is a primary metabolite and widely used as biofuel.
It is also used as a chemical feedstock for many chemical
industries, such as solvent for dyes, oils, waxes, explosives,
cosmetics, laboratories and as a disinfectant. According to
Renewable Fuels Association (2015), approximately 97.0
billion liters of ethanol was produced worldwide in 2015,
and the USA was the largest producer of bioethanol (*56
billion liters), followed by Brazil (*26 billion liters). It is
reported that annually over 98% of bioethanol is made
from corn. The maximum proportion of total ethanol (*90
to 95%) is produced using microbial fermentation tech-
nology (Sarris and Papanikolaou 2016). Recombinant
microorganisms, such as E. coli, Klebsiella oxytoca and
Clostridium thermocellum are involved in fermentative
production of ethanol using different carbon sources
(Moniruzzaman and Ingram 1998; Demain et al. 2005).
Genetically engineered microbial strain represent [95%
ethanol as a fermentation products, whereas wild type
E. coli produce a mixture of acids (Demain 2007).
Global glycerol market was estimated $1.64 billion in
2014 and is expected to reach nearly $3 billion by 2022 at a
growth rate of 7.9%. Global glycerol market size was
estimated 2443.9 tons in 2014 and is expected to witness
annual gains at over 6.5% from 2015 to 2022 (Glycerol
Market Size 2015). Glycerol is used for different applica-
tions in foods and beverages, polyether polyols, personal
care and pharmaceuticals, alkyd resins, and tobacco
humectants. An osmotolerant yeast, Candida glycerino-
genes has been reported for microbial production of glyc-
erol *130 g/L with a yield of[60% and productivity of
[30 g/L day (Wang and Zhuge 1999; Wang et al. 2001).
Antibiotics
The antibiotic period began in 1929 with the discovery of
penicillin from a fungal sp. Penicillin notatum and its
commercial production flourished in the 1940s (Demain
and Fang 2000). Later, a number of antibiotics have been
discovered specifically from fungi and actinomycetes in
quest of more effective pharmacological properties and to
combat new pathogens. Continuing research in this area led
to the discovery of a series of antibiotics, such as cepha-
losporin, tetracycline, macrolids, ansamacrolids, amino-
glycosides, chloramphenicol, glycopeptides, peptide
inhibitors, anthracyclins and antifungal antibiotics (Kies-
lich 1986; Hassan et al. 2012). Nowadays, antibiotics are
used for a wide range of applications, such as in
chemotherapy, veterinary, plant pathology, food preserva-
tion and in research laboratories. These compounds inhibit
several pathways, such as nucleic acid synthesis, protein
synthesis, cell wall formation, and electron transport
pathway (Demain 2007). Some of the microbial species
have been reported for their efficient ability to produce a
variety of antibiotics. The actinomycetes are responsible
for the production of largest proportion (*75%) of
antibiotics and the Streptomycetes are the largest producer
of antibiotics (Omura 1992; Miyadoh 1993; Zedan 1993;
Lazzarini et al. 2000; Berdy 2005). Besides, Strepto-
mycetes are also involved in the potential production of a
range of pharmaceutical agents including antiparasitic,
anticancer, immunosuppressive and enzyme inhibitors.
Antibiotics can be classified in different ways, such as
based on their chemical structure, biosynthesis pathway,
source, mode of action, route of administration, and their
effective range. Tetracyclines, the most extensively used
broad-spectrum antibiotics, are used considerably in the
treatment of diseases caused by a wide range of microor-
ganism including gram-positive and gram-negative bacte-
ria, protozoan parasites, chlamydiae, rickettsiae and
mycoplasma (Chopra and Roberts 2001). Ciprofloxacin,
another broad-spectrum antibiotic, is effective in the
 15 Page 6 of 14 3 Biotech  (2017) 7:15 
123
treatment of urinary tract infections, chancroid, gastroin-
testinal infection, skin and bone infections and gonorrhea
(Davis et al. 1996).
Cephalosporins have a broader spectrum effect against
infections and are less likely to be associated with ana-
phylactic reactions as compared to penicillin (Bhattacharya
2010). Antibiotics market shared around 4.5% of the global
pharmaceutical market. The global market of systemic
antibiotics was nearly $40.6 billion in 2015 and is expected
to reach about $44.7 billion in 2020 at a compound annual
growth rate (CAGR) of 2.0% from 2015 to 2020 (Antibi-
otics 2016).
The global consumption of antibiotic in 2010 was
reported highest in India with 13 billion standard units
followed by China (10 billion SU) and USA (7 billion SU).
The total antibiotic consumption during 2000–2010 was
grown by about 35% from 54,000 to 73,500 million stan-
dard units. Meanwhile, the consumption of the most
common first-line antibiotics penicillin and cephalosporins
were increased by 41% and accounted for nearly 60% of
total consumption (Van Boeckel et al. 2014; Gelband et al.
2015).
Consumption of two last resort antibiotics carbapenems
and polymixins were also increased by approximately 40
and 13% respectively. Carbapenems are used against most
difficult Gram-negative infections while polymixins are
used to treat multi-drug resistant infections, such as car-
bapenem-resistant Enterobacteriaceae. Besides, significant
increases were also observed for monobactams ([2000%),
glycopeptides ([230%), cephalosporins ([90%), and flu-
oroquinolones ([60%) for the same period. At present,
consumption of antibiotics in poultry, swine, and cattle to
treat infections and to accelerate animal growth is higher
than used for the entire human therapeutic purposes.
Worldwide, antibiotics consumptions by livestock was
estimated 63,200 tons in 2010 and accounted for nearly
67% of the total antibiotics produced (Pagel and Gautier
2012; Bbosa and Mwebaza 2013; Laxminarayan et al.
2013; Laxminarayan 2014; van Boeckel et al. 2014; Gel-
band et al. 2015; van Boeckel et al. 2015).
Antibiotics are amongst most frequently prescribed
medicine used in healthcare as life saving drugs and hence
should be used carefully in treating infections. However,
unnecessary and incorrect dosing of antibiotics without
proper prescription is the most important factor for
antibiotic resistance worldwide. Continuously increasing
drug resistance can be prevented through immunization,
hand washing, safe food preparation and using antibiotics
through proper prescription only when necessary (http://
www.cdc.gov/drugresistance/about.html).
Currently, the key manufacturers in the global antibi-
otics market are Pfizer Inc., Merck and Co., Eli Lilly and
Co., Cubist pharmaceuticals, Johnson & Johnson from
USA; AstraZeneca and GlaxoSmithKline PLC from UK,
and Sanofi-Aventis from France (Antibiotics 2016).
Antitumor agents
Tumors are generally treated by surgical removal, radiation
and chemotherapy. Surgical methods and radiation therapy
are inefficient to treat metastatic cancer and therefore,
chemotherapy is predominantly helpful in treatment of
cancer that has spread to other parts of the body than origin
site. According to World Health Organization (WHO),
approximately 8.2 million people die annually from cancer,
an estimated 13% of all deaths worldwide, and are
expected to increase by *70% new cases of cancer over
the next two decades (http://www.who.int/cancer/en/).
Many microbial metabolites have been reported for effec-
tive anticancer properties in healthcare after the discovery
of first anticancer agent, actinomycin by Wakesman and
Woodruff. Approximately, 60% of the compounds with
anticancer properties are derived from natural sources
(Demain and Sa´nchez 2009). Few microbial products with
antineoplastic activities have been illustrated in Table 2.
Many of the chemotherapeutic agents used in cancer
treatment are secondary metabolites produced by
microorganisms, especially of the genus Streptomyces
(Demain and Vaishnav 2011; Manivasagan et al. 2014).
The chemotherapy market is currently the fastest
growing in the pharmaceutical industry, driven by the
magnitude of the disease worldwide and growing under-
standing of potential therapeutic targets revealed by the
molecular genetics assessments of cancer biology.
Other therapeutic agents
Apart from antibacterial and antitumor agents, other valu-
able compounds including enzyme inhibitors, immuno-
suppresants, and alkaloids are of pharmacological
importance and also produced by microorganisms.
Immunosuppressant drugs are required to reduce the
efficacy of the immune system to prevent rejection of
organ transplants and to restrict autoimmune diseases. A
number of compounds of microbial origin have been
reported for their significant role in suppression of
immune response in organ transplant field. Important
microbial metabolites, such as cyclosporine A from
Tolypcladium nivenum, sirolimus from Streptomyces
hygroscopicus, tacrolimus from S. tsukubaenis,
mycophenolate mofetil from Penicillium stoloniferum
and, gliotoxin from Aspergillus and trichoderma have
been reported for their immunosuppressive activities and
an effective role in organ transplants (Vezina et al. 1975;
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Borel et al. 1976; Kino et al. 1987; Demain 2007). In
addition, the analogs of rapamycin, such as everolimus
(RAD001), tensirolimus (CCI-799) and ARIAD
(AP23573) have been developed for their use in heart
transplantation and possible role in the treatment of dif-
ferent types of cancer (Demain and Sa´nchez 2009).
Enzyme inhibitors have received increasing attention for
their potential utilization in medicine and agriculture. A
number of enzyme inhibitors for different industrial
applications have been isolated from microorganisms.
Amylase inhibitors (starch blockers) prevent absorption of
dietary starches by the body and are useful to control and
treatment of carbohydrate dependent diseases, such as
diabetes, obesity and hyperlipemia (Jayaraj et al. 2013). In
addition, the amylase inhibitors have also been reported for
the treatment of rumen acidosis (Banks et al. 2001).
Microbial a-amylase inhibitors are paim from Strepto-
myces corchorushii and TAI-A and TAI-B from Strepto-
myces calvus TM-521 (Song et al. 2014). The clavulanic
acid is derived from Streptomyces clavuligerus. It acts as
an inhibitor of b-lactamase and used to overcome antibiotic
resistance (Adrio and Demain 2010).
Lipstatin is a pancreatic lipase inhibitor that is produced
by Streptomyces toxytricini and it obstructs gastrointestinal
absorption of fat and therefore plays an important role in
the treatment of obesity and diabetes (Rodgers et al. 2012).
Acarbose, a pseudotetrasaccharide, contains valienamine
which is used to inhibit intestinal a-glucosidase and
sucrase. It is produced by Actinoplanes sp. SE 50 and
useful to reduce starch breakdown in the intestine, and
hence used in the treatment of type 2 diabetes mellitus
diabetes in humans (Demain and Sa´nchez 2009). Protease
inhibitors, such as antipain, leupeptin and chymostatin
have also find important applications in the treatment of
AIDS, hepatitis, pancreatitis and cancer. These protease
inhibitors are produced by different species of the genus
Streptomyces (Butler 2008). Enzyme inhibitors of fungal
origin are also used against various diseases, such as Alz-
heimer’s disease, diabetes, cancer and many more (Pater-
son 2008).
Alkaloids are heterocyclic organic nitrogen containing
compounds that have pharmaceutical values including
anticancer and anti-malarial effects and are synthesized
from amino acids (ornithine, lysine, aspartic acid,
Table 2 Anticancer agents from microorganisms
Anticancer agent Source Type of cancer Function
Aclacinomycin Streptomyces galilaeus Lung cancer Inhibition of nucleic acids and protein
synthesis
Calicheamicin Micromonospora echinospora Acute myelogenous leukemia Cleavage of DNA




Streptomyces griseus Breast and urinary bladder cancer Inhibition of RNA synthesis
Actinomycin D Streptomyces antibioticus Wilm’s tumor in children Inhibition of RNA synthesis
Taxol (paclitaxel) Taxomyces andreanae,
Nodulisporium sylviforme
Breast cancer, Kaposi sarcoma Microtubule depolymerization
Mitomycin C Streptomyces caespitosus Breast, stomach, oesophagus, bladder Inhibition of DNA replication
Mithramycin Streptomyces plicatus, S.
argillaceus, S.
atroolivaceus
Bone and testicular tumour Inhibition of of RNA synthesis, mRNA
expression and protein synthesis
Daunomycin Streptomyces peucetius Acute myeloid leukemia, acute
lymphocytic leukemia, Neuroblastoma
Inhibition of DNA replication




Neocarzinostatin Streptomyces carzinostaticus Liver cancer Proteolysis of histone, degradation of
DNA
Thiocoraline Micromonospora marina Colon cancer Inhibition of DNA replication
Alteramide Alteromonas sp. Leukemia, lymphoma, epidermal
carcinoma
DNA fragmentation
Epothilone Sorangium cellulosum Breast cancer Microtubule depolymerization
Pentostatin
(deoxycoformycin)
Streptomyces antibioticus Hairy cell leukemia, acute lymphocytic
leukemia, prolymphocytic leukemia
Inhibition of DNA
Streptozotocin Streptomyces achromogenes Pancreatic islet cell cancer Inhibition of DNA
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phenylalanine, tyrosine and tryptophan) by microorgan-
isms, plants and some animals (Marienhagen and Bott
2013; Wang et al. 2016). For example, nicotine is derived
from ornithine whereas ephedrine and morphine are
derived from phenylalanine and tyrosine, respectively. The
ergot alkaloids were originally derived from ergot, a scle-
rotium (twisted mat of fungal hyphae). Most of these
alkaloids are derived from the Claviceps sclerotium.
Besides, the alkaloids have also been reported by other
fungi including Aspergillus, Penicillium, and Rhizopus.
The naturally occurring ergot alkaloids can be divided into
lysergic acid derivatives and clavine alkaloids. Ergot
alkaloids have been utilized for various diseases, for
example ergometrine, ergonovine, and ergotamine for
inducing labor in mid-wifery, stopping bleeding after birth,
and blocking the sympathetic system for treating
migraines, respectively. In addition, the diethylamide
derivate of lysergic acid is a powerful hallucinogenic drug
for experimental psychotherapy and dihydro derivates of
clavinet alkaloid used as strong stimulants of oxytoxic
(milk secreting) activity or of uterine contractions.
Semisynthetic ergot alkaloids have other major applica-
tions as potential therapeutic agents, for example, nigeri-
coline is used in peripheral and cerebral circulation
disorder treatment and Lysenyl treats hypertension and
migraine. Some other ergot alkaloids have also been
reported as pharmaceutical drugs for treatment of prostrate
cancer, Parkinson’s disease and lack of milk production
after child birth (Schiff 2006; Okafor 2007; Gerhards et al.
2014; Mahmood and Mahmood 2015).
Antiparasitic compounds are used to inhibit the growth
and reproduction of parasite organisms that live on the
body of humans and animals and can cause serious health
problems including death of the host. More than 3200
varieties of parasites have been reported so far from pro-
tozoa and helminths. According to WHO, approximately
25% of global population is infected with roundworm
(Demain and Sa´nchez 2009). The significance of antipar-
asitic drugs can be evaluated by the fact that antiparasitic
drug discoverers, Satoshi Omura, William Campbell and
Youyou Tu shared the 2015 Novel Prize in Physiology or
Medicine for their work on avermectin and artemisinin
(World report 2015). Avermectin and its derivatives are
extremely effective against river blindness, lymphatic
filariasis, and several other parasitic infections while arte-
misinin is used for most effective treatment for malaria.
Omura and coworkers reported eight compounds, which
are produced as secondary metabolites by Streptomyces
avermitilis and were named avermectins (Stapley 1982)
and these compounds possessed activity against nemath-
elminthes and arthropods. Ivermectins is a semisynthetic
derivative of avermectin compounds, which is used to
control human onchocerciasis and strongyloidiasis (Shikiya
et al. 1992). Another derivative selamectin is highly
effective against heartworms and fleas in companion ani-
mals (Michael et al. 2002). Actinomycetes produce poly-
ether antibiotics, such as monensin, lasalocid A and
salinomycin, which are used to control poultry coccidiosis
(Shiomi and Omura 2004). The application of anticoc-
cidiales has significantly reduced the mortality and pro-
duction loss caused by coccidiosis in poultry industry
(Westley 1977).
Biopesticides and plant growth regulators
Chemical pesticides, such as halogenated, carbamate and
organophosphorus compounds have been used widely for
agriculture system. Their use as pest control results in
several problems, such as toxic effect on wild life, human
and domestic animals; chemical changes on undesired
insects/pests on their predators, parasites and contamina-
tion of ground water (Lacey and Siegel 2000; Canan 2013;
Nawaz et al. 2016). Biopesticides include biofungicides
(Trichoderma), bioherbicides (Phytopthora) and bioinsec-
ticides (Bacillus thuringiensis, B. sphaericus) are preferred
over conventional pesticides due to biodegradable nature,
highly effectiveness, target specificity and less environ-
mental risks (Canan 2013). The global biopesticides market
is expected to reach $6.60 billion by 2020 at a CAGR of
18.8% for the period from 2015 to 2020 (Biopesticide
market 2015).
Biological pesticides based on pathogenic microorgan-
isms specific to a target pest and pose less threat to the
ecosystem. The potential benefits to agriculture and public
health programmes through the use of biopesticides are
considerable. Over 100 bacteria have been identified as
insect pathogens, among them Bacillus thuringiensis (Bt),
a gram-positive endospore forming bacteria, has got the
maximum importance as an insecticidal bacterium to
control caterpillar pests, fly and mosquito larvae, and
beetles (Argolo-Filho and Loguercio 2014; Nawaz et al.
2016). Bt produces insecticidal endotoxin protein during
spore formation that binds to and destroy the cellular lining
of the digestive tract, causing the insect to stop feeding and
die (Schunemann et al. 2014). The protein kills mainly
caterpillars of the Lepidoptera (butterflies and moths),
mosquito larvae, and simuliid blackflies. Bt sprays are used
on fruit and vegetable crops, on broad-acre crops such as
maize, soya bean and cotton (Meadows 1993).
Various subspecies of Bt are used for their different
function as bioinsectisides, such as to control beetle larvae
(var. tenebrionis), caterpillars (var. kurstaki, entomocidus,
galleriae and aizawai), and mosquito and blackfly larvae
(var. israeliensis) (Lambert et al. 1992; Milner 1994).
Bacillus sphaericus is another insecticidal bacterium that
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has been used to control mosquito species. Certain strains
of Bacillus subtilis, B. pumilus, Pseudomonas fluorescens,
P. aureofaciens and Streptomyces spp. prevent plant dis-
eases by outcompeting plant pathogens in the rhizosphere,
producing anti-fungal compounds and promoting plant and
root growth. They are used against a range of plant
pathogens including damping-off and soft rots (Canan
2013; Chatzipavlidis et al. 2013).
Biofungicides have been used in both the phylloplane
and rhizosphere to control plant diseases caused by fungi,
bacteria or nematodes including some insect pests and
weeds. The most common commercial fungal bio-pesti-
cides used in agricluture and forestry are Trichoderma spp.
and Beauveria bassiana. Trichoderma harzianum is an
antagonist of Rhizoctionia, Pythium, Fusarium and other
soil-borne pathogens. Beauveria bassiana and Metarhizium
anisopliae are parasitic fungi found on many insect species.
Beauveria bassiana has been proved effective in control-
ling crop pests such aphids, thrips and whitefly pesticide
resistant strains. Metarhizium anisopliae is used against
spittlebugs on sugarcane and grassland and furthermore for
the control of locust and grasshopper pests in Africa and
Australia. Coniothyrium minitans is a mycoparasite applied
against Sclerotinia sclerotiorum (Chandler et al. 2011;
Chatzipavlidis et al. 2013).
Herbicides are widely used in agriculture, industry and
urban areas for weed management. With increasing global
environmental consciousness, bioherbicides are proved
highly effective for weed control in eco-friendly manner.
Microbial herbicides can be divided into microbial prepa-
rations (microorganisms that control weeds) and microbial
derived herbicides. Products based on Colletotrichum spp
and Phytophthora are used commercially against agricul-
tural weeds (Demain and Sa´nchez 2009; Chandler et al.
2011). The global bioherbicides market was around $973
million in 2015 and is expected to grow at a CAGR of
10.87% for the period from 2015 to 2020. The driving
factors for the growth of the market are the ecofriendly
nature of bioherbicides, increasing public awareness and
lesser development of pest resistance (Global Bioherbi-
cides Market 2016). Research and development in the field
of biopesticide applications greatly reduce the environ-
mental pollution caused by the chemical synthetic insec-
ticides and promotes sustainable development of
agriculture. Pesticides are employed in modern agriculture
to control pests and to increase crop yield.
Plant growth regulators, also called plant hormones
are chemical compounds that act as messengers to reg-
ulate growth of plants and differentiation of plant cells.
There are currently five groups of plant hormones:
auxins, gibberellins, cytokinins, abscisic acid and ethy-
lene. These plant hormones work together to regulate the
growth and development of cells (Spence and Bais
2015). The plant growth regulators market was estimated
to be valued at $1.6 billion in 2015 and is projected to
grow at a CAGR of 3.6% from 2015 to 2020 to reach an
expected value of $1.91 billion by 2020 (Plant Growth
Regulators 2015). Among the types of plant growth
regulators, gibberellins accounted for the largest market
share followed by cytokinins and auxins. Gibberellins are
used on a large scale for extensive production and cul-
tivation of fruits and vegetables and it is mainly involved
in early embryo growth, seed germination, stem elon-
gation and flowering. The worldwide consumption of
gibberellic acid is approximately 60 tons annually. A
number of microorganisms are utilized to produce these
hormones (MacMillan 2001; Yurekli et al. 1999;
Karadeniz et al. 2006; Tsavkelova et al. 2006). The
global leading manufacturers of plant hormones are FMC
Corporation and The Dow Chemical Company from
USA, Syngenta AG (Switzerland), BASF SE (Germany)
and Nufarm Limited (Australia) (Plant Growth Regula-
tors 2015).
Conclusion
Microorganisms, primary source of nutrients, are essential to
all life forms and are efficiently involved in healthcare,
agriculture and nutrition. These tiny entities are involved in
the preparation of variety of foods and also used as feed
supplements. Microorganisms produce antibiotics, antitu-
mor agents, immunosuppressants, alkaloids, and enzyme
inhibitors, which are used in the treatment of infectious as
well as fatal diseases worldwide and play a key role in
reduced mortality rate and better human life expectancy.
Application of enzymes has been increasing continuously as
microbial enzymes have significant potential for many
industries, including pharmaceuticals, food, feed, beverages,
detergents, leather processing and paper and pulp to meet
demand of rapidly growing population. Pesticides and
growth regulators of microbial origin have proved their
significant potential in sustainable agriculture development
and consequently in the development of green environment.
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